Trine Meldgaard Lund

Trine Meldgaard Lund serves as an Associate Professor in the Department of Drug Design and Pharmacology within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research focuses on optimizing pharmacotherapy and clinical trial designs through advanced pharmacometric modeling. With 85 research outputs and active collaborations across multiple countries, she maintains a significant international research presence.

Her primary research domain centers on Population PKPD modelling and Pharmacometrics, specifically characterizing pharmacokinetic-pharmacodynamic relationships to identify sources of drug response variability. Key projects include fixed-dose combination development, model-based dose finding, PK meta-modeling of morphine, and investigating CYP enzyme differences in pediatric populations. Her work demonstrates strong translational impact through clinical pain trials and therapeutic drug monitoring applications.

Lund's research portfolio shows consistent output in high-impact journals, with recent 2025 publications spanning nephrology, oncology, geriatric pharmacology, and cannabinoid therapeutics. Her work frequently addresses methodological challenges in clinical trial design and demonstrates particular expertise in modeling complex drug interactions and age-related pharmacokinetic variability. The collaborative nature of her research is evident through extensive co-authorship networks across Scandinavian institutions.

As an educator, Lund teaches Pharmacokinetics and Pharmacodynamics across multiple courses including Basic Pharmacology, Principles of Pharmacology, and Organ-related Pharmacology. She also leads specialized elective courses and PhD-level instruction through the MIND program. Her academic leadership extends to organizing 9 significant professional activities including symposia on precision medicine, clinical trial design, and therapeutic drug monitoring for major Danish pharmacological societies.